Amgen stock dipped late Tuesday after the biotech giant reported adjusted income of $3.70 per share on $5.9 billion in sales for its first quarter ended March 31.
On average, analysts polled by FactSet expected Amgen (AMGN) to earn $4.04 per share and $6.27 billion in sales.
In the year-earlier period, Amgen earnings were $4.22 a share and sales were $6.16 billion.
For the year, Amgen guided to adjusted earnings of $16-$17 per share and $25.8 billion to $26.6 billion in sales. Analysts called for profit of $16.84 a share and $26.4 billion in sales.
In after-hours trading on the stock market today, Amgen stock fell a fraction near 255.10.
https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q1-2021/?src=A00220
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.